Suppr超能文献

在体外连续血液透析滤过模型中,吸附作用和红细胞压积水平对更昔洛韦清除率的影响。

Contribution of Adsorption and Hematocrit Levels to Ganciclovir Clearance in an in Vitro Continuous Hemodiafiltration Model.

机构信息

Graduate School of Pharmaceutical Sciences, Chiba University.

Division of Pharmacy, Chiba University Hospital.

出版信息

Biol Pharm Bull. 2024;47(7):1396-1404. doi: 10.1248/bpb.b24-00268.

Abstract

Estimation of the continuous hemodiafiltration (CHDF) clearance (CL) of ganciclovir (GCV) is crucial for achieving efficient treatment outcomes. Here, we aimed to clarify the contribution of diafiltration, adsorption, and hematocrit level to the CL of GCV in an in vitro CHDF model using three membranes: polyacrylonitrile and sodium methallyl sulfonate copolymer coated with polyethylenimine (AN69ST); polymethylmethacrylate (PMMA); and polysulfone (PS). In vitro CHDF was performed with effluent flow rates (Qe) of 800, 1500, and 3000 mL/h. The initial GCV concentration was 10 µg/mL while that of human serum albumin (HSA) was 0 or 5 g/dL. The CL, diafiltration rates, and adsorption rates were calculated. The whole blood-to-plasma ratio (R) of GCV for a hematocrit of 0.1 to 0.5 was determined using blood samples with 0.5 to 100 µg/mL of GCV. The in vitro CHDF experiment using AN69ST, PMMA, and PS membranes showed that the total CL values were almost the same as the Qe and not influenced by the HSA concentration. The diafiltration rate exceeded 88.1 ± 2.8% while the adsorption rate was lower than 9.4 ± 9.4% in all conditions. The R value was 1.89 ± 0.11 and was similar at all hematocrit levels and GCV concentrations. In conclusion, diafiltration mainly contributes to the CL of GCV, rather than adsorption. Hematocrit levels might not affect the relationship between the plasma and blood CL of GCV, and the CL of GCV can be estimated from the Qe and R, at least in vitro.

摘要

估算连续血液透析滤过 (CHDF) 中更昔洛韦 (GCV) 的清除率 (CL) 对于实现高效的治疗效果至关重要。本研究旨在通过使用三种膜(聚甲基丙烯腈和甲基丙烯磺酸钠共聚体涂覆聚乙烯亚胺(AN69ST)、聚甲基丙烯酸甲酯 (PMMA) 和聚砜 (PS))的体外 CHDF 模型阐明在血液中的清除率与透析滤过、吸附和血细胞比容水平之间的关系。以 800、1500 和 3000 mL/h 的流出速度 (Qe) 进行体外 CHDF。初始 GCV 浓度为 10 μg/mL,人血清白蛋白 (HSA) 浓度为 0 或 5 g/dL。计算 CL、透析滤过率和吸附率。使用 GCV 浓度为 0.5 至 100 μg/mL 的血液样本测定血细胞比容为 0.1 至 0.5 时 GCV 的全血-血浆比 (R)。使用 AN69ST、PMMA 和 PS 膜进行的体外 CHDF 实验表明,总 CL 值与 Qe 几乎相同,不受 HSA 浓度的影响。在所有条件下,透析滤过率均超过 88.1±2.8%,而吸附率均低于 9.4±9.4%。R 值为 1.89±0.11,在所有血细胞比容水平和 GCV 浓度下均相似。总之,透析滤过主要影响 GCV 的 CL,而不是吸附。血细胞比容水平可能不会影响 GCV 的血浆和血液 CL 之间的关系,并且至少在体外可以从 Qe 和 R 来估计 GCV 的 CL。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验